Adheris Health Limited · ASX:AHE
Adheris Health — Shareholder Meeting (November 2026)
16 slides from Adheris Health's shareholder meeting presentation, Nov 18, 2026
Slide 1: Annual General Meeting 2026 – Chair's Address and CEO Presentation
Adheris Health Limited ABN 17 145 327 617 Suite 287, Tenancy 111, 793 Burke Road, Camberwell, VIC 3124 adheris.com/investors ASX RELEASE (ASX: AHE) For personal use only Annual General Meeting 2026 – Chair’s Address and CEO Presentation 18 November 2026 - Adheris Health Limited (“Adheris Health” or
Slide 2: Chair's Address AGM 2026
Chair’s Address AGM 2026 18 November 2026 – Good morning and thank you for joining us today. For personal use only On behalf of the Board, I would like to welcome shareholders to the 2026 Annual General Meeting of Adheris. The past year has been a period of significant change for Adheris. As shareho
Slide 3: Chair's Address closing remarks
Finally, I would like to thank our shareholders for your patience, and continued support during this period of reset and transformation. Your Board remains committed to ensuring that Adheris is well positioned to capture the opportunities ahead. Thank you. For personal use only © 2026 Adheris Health
Slide 4: CEO Presentation – John Ciccio, CEO & Managing Director
rsonal use only FY26 AGM PRESENTATION 18 November 2026 John Ciccio – CEO & Managing Director 1 FY26 AGM Presentation | © 2026 Adheris Health. All rights reserved.
Slide 5: Important notice and disclaimer
Important notice and disclaimer The information contained in this presentation does not constitute financial advice and This presentation has not been filed, lodged, registered, reviewed, or approved by any is not intended to be relied upon as advice to investors or potential investors. The regulato
Slide 6: Leader in Patient Engagement Solutions
Leader in Patient Engagement Solutions Impact rsonal use only ~133 Million 500+ Million Proven Results Sponsored messages ~65% of patients returned to therapy Americans reachable through our network of 25K pharmacies delivered in past 5 years >24% avg SMS click-through rates +11% avg awareness progr
Slide 7: Agenda
Agenda rsonal use only Positive Start to FY27 Strategic Priority Review CY27 Pipeline Update 4 FY26 AGM Presentation | © 2026 Adheris Health. All rights reserved.
Slide 8: Positive Start to FY27
rsonal use only Positive Start to FY27 5 FY26 AGM Presentation | © 2026 Adheris Health. All rights reserved.
Slide 9: Positive Start to FY27
Positive Start to FY27* Revenue, gross profit and gross margin increased on pcp and substantially on prior quarter, reflecting stronger out of cycle booking activity and improved program execution rsonal use only Revenue Gross Profit Gross Margin Underlying Product Cash at Bank Q1 FY27 Margin $6.4M
Slide 10: Strategic Priority Review
rsonal use only Strategic Priority Review 7 FY26 AGM Presentation | © 2026 Adheris Health. All rights reserved.
Slide 11: Five Priorities: Delivered in FY26 and FY27 Focus
Five Priorities: Delivered in FY26 and FY27 Focus ✓ Enhance Digital rsonal use only Build Scalable Diversify Revenue Sell Higher-margin Expand Pharmacy Operation Solutions Network Engagement • Maintain a broadly flat • Reduce reliance on • Refocus our business • Increase the breadth and • Level up o
Slide 12: Enhanced Digital Experience
Enhanced Digital Experience Powering the next generation of patient engagement through a customized experience rsonal use only Our engagement platform is able to customise the SMS based on Express Markets, #12- 3456, (555) 555-1212: segment and lead the patient Jenn, we’re here to support through a
Slide 13: CY27 Pipeline Update
rsonal use only CY27 Pipeline Update
Slide 14: CY27 Pipeline: Advancing Through Defined Stages
CY27 Pipeline: Advancing Through Defined Stages 66% of value at proposal stage or later, up from 52% at 21 August rsonal use only 4 Negotiation or Verbal Sales stage 1 Qualifying Lead 2 Presentation 3 Proposal Submitted 5 Contract Routing Award Stage weighting 10% 25% 50% 75% 90% Share of pipeline v
Slide 15: CY27 Pipeline: Larger and Broader
CY27 Pipeline: Larger and Broader Strong growth since our August and October updates across opportunities, customers, brands, and value rsonal use only Pipeline value growth since 21 August (not to time scale) 128 50 105 Total value Weighted value Opportunities Customers Brands +60% +27% since 21 Au
Slide 16: Thank you.
rsonal use only Thank you.